OPIANT PHARMACEUTICALS, INC. Quarterly Income Tax Expense (Benefit) in USD from Q3 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2010 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $8.55K.
  • Opiant Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2022 was $65.3K.
  • Opiant Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $24.3K.
  • Opiant Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was -$426K, a 140% decline from 2019.
  • Opiant Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2019 was -$177K, a 446% decline from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $65.3K $8.55K +$8.55K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $56.8K $32.5K +$32.5K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $24.3K $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $24.3K $24.3K +$489K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 -$465K $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$465K $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$465K $0 -$39K -100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$426K -$465K -$344K -286% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$81.4K $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$81.4K $0 +$56.8K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$138K $39K +$39K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$177K -$120K -$139K -759% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$38.5K $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$38.5K -$56.8K -$56.8K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $18.3K $0 -$33K -100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $51.3K $18.3K -$229K -92.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 $280K $0 -$550K -100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $830K $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $830K $33K +$33K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $797K $247K +$247K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 $550K $550K +$550K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $0 $0 -$550K -100% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $550K $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $550K $0 $0 Nov 1, 2016 Jan 31, 2017 10-Q 2017-03-15
Q3 2016 $550K $0 $0 Aug 1, 2016 Oct 31, 2016 10-Q 2016-12-15
Q2 2016 $550K $550K +$550K May 1, 2016 Jul 31, 2016 10-K 2019-03-21
Q1 2016 $0 $0 $0 Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 $0 $0 $0 Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-15
Q3 2015 $0 $0 $0 Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-15
Q2 2015 $0 $0 May 1, 2015 Jul 31, 2015 10-K 2016-10-28
Q1 2015 $0 Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 $0 Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-15
Q3 2014 $0 Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-14
Q4 2012 $0 $0 $0 Nov 1, 2012 Jan 31, 2013 10-Q 2013-03-18
Q3 2012 $0 $0 $0 Aug 1, 2012 Oct 31, 2012 10-Q 2012-12-20
Q2 2012 $0 $0 $0 May 1, 2012 Jul 31, 2012 10-K/A 2012-11-01
Q1 2012 $0 $0 $0 Feb 1, 2012 Apr 30, 2012 10-Q 2012-06-14
Q4 2011 $0 $0 $0 Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 $0 $0 $0 Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-20
Q2 2011 $0 $0 May 1, 2011 Jul 31, 2011 10-K/A 2012-11-01
Q1 2011 $0 Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 $0 Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q3 2010 $0 Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.